Operating Income (Loss), Adjusted
Boston Scientific·Business Segments·2 segments
Breakdown
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|
| Cardiovascular | $1.05B | $1.07B | $1.14B | $1.05B |
| MedSurg | $528.00M | $599.00M | $566.00M | $575.00M |
| Total | $528.00M | $599.00M | $566.00M | $575.00M |
Segments
MedSurgView metric
CardiovascularView metric